Forodesine

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameForodesine
Drug Alias Namepurine nucleoside phosphorylase inhibitors (Nitor Therapeutics)NTR-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionPurine nucleoside phosphorylase inhibitorsToll like receptor 2 agonistsToll like receptor 4 agonists
TargetsToll like receptor 2Purine nucleoside phosphorylaseToll like receptor 4
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNitor Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesNitor Therapeutics
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A